Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?

Abstract

We report a successful case of living-donor lobar lung transplantation (LDLLT) for therapy-resistant broncho-bronchiolitis obliterans (BBO) after allogeneic hematopoietic stem cell transplantation (HSCT). Bronchiolitis obliterans (BO) is one of the late-onset noninfectious pulmonary complications that occur after allogeneic HSCT and is usually resistant to immunosup-pressive therapy. A 17-year-old girl with acute lymphoblastic leukemia (ALL) had undergone allogeneic bone marrow transplantation (BMT) from an HLA-matched sibling in 1997. Five years later, she relapsed with ALL and was treated with chemotherapy following stem cell rescue and donor lymphocyte infusion from the original BMT donor. Eight months later, BBO resistant to immunosuppressive therapies, including rituximab, developed in combination with chronic graft-versus-host disease (GVHD). In February 2004, the patient underwent LDLLT from 2 other family members who were mismatched at 3 HLA loci. The patient has been in good health for more than 30 months following LDLLT and shows no sign of BBO in the transplanted lungs, just as with other patients who have undergone lung transplantation for BO associated with chronic GVHD. LDLLT may therefore be considered a viable therapeutic option for the treatment of BO after allogeneic HSCT.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Krowka MJ, Rosenow EC 3rd, Hoagland HC. Pulmonary complications of bone marrow transplantation.Chest. 1985;87: 237–246.

    Article  PubMed  CAS  Google Scholar 

  2. 2.

    Soubani AO, Miller KB, Hassoun PM. Pulmonary complications of bone marrow transplantation.Chest. 1996;109:1066–1077.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. 3.

    Chan CK, Hyland RH, Hutcheon MA. Pulmonary complications following bone marrow transplantation.Clin Chest Med. 1990;11:323–332.

    PubMed  CAS  Google Scholar 

  4. 4.

    Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation.Br J Haematol. 1998;100:680–687.

    Article  PubMed  CAS  Google Scholar 

  5. 5.

    Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation.Bone Marrow Transplant. 2001;28:425–434.

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Duncker C, Dohr D, Harsdorf S, et al. Non-infectious lung complications are closely associated with chronic graft-versus-host disease: a single center study of incidence, risk factors and outcome.Bone Marrow Transplant. 2000;25:1263–1268.

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Sakaida E, Nakaseko C, Harima A, et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.Blood. 2003;102: 4236–4242.

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.Biol Blood Marrow Transplant. 2003;9:657–666.

    Article  PubMed  Google Scholar 

  9. 9.

    Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG.Blood. 1988;72:621–627.

    PubMed  CAS  Google Scholar 

  10. 10.

    Paz HL, Crilley P,Topolsky DL, Coll WX, Patchefsky A, Brodsky I. Bronchiolitis obliterans after bone marrow transplantation: the effect of preconditioning.Respiration. 1993;60:109–114.

    Article  PubMed  CAS  Google Scholar 

  11. 11.

    Takeuchi J, Kyo T, Naito K, Sao H, et al. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study.Leukemia. 2002;16:1259–1266.

    Article  PubMed  CAS  Google Scholar 

  12. 12.

    Ratanatharathorn V, Ayash L, Reynolds C, et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.Biol Blood Marrow Transplant. 2003;9: 505–511.

    Article  PubMed  CAS  Google Scholar 

  13. 13.

    DeMeo DL, Ginns LC. Clinical status of lung transplantation.Transplantation. 2001;72:1713–1724.

    Article  PubMed  CAS  Google Scholar 

  14. 14.

    Cohen RG, Starnes VA. Living donor lung transplantation.World J Surg.2001;25:244–250.

    Article  PubMed  CAS  Google Scholar 

  15. 15.

    Inoue K, Ogawa H, Yamagami T, et al. Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels.Blood. 1996;88:2267–2278.

    PubMed  PubMed Central  CAS  Google Scholar 

  16. 16.

    Yokoi T, Hirabayashi N, Ito M, et al. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group.Virchows Arch. 1997;431:275–282.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. 17.

    Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF. Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients.Eur Respir J. 1995;8:551–558.

    PubMed  PubMed Central  CAS  Google Scholar 

  18. 18.

    Clark JG, Crawford SW, Madtes DK, Sullivan KM. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course.Ann Intern Med. 1989;111:368–376.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. 19.

    Yousem SA.The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients.Hum Pathol. 1995;26:668–675.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  20. 20.

    Paz HL, Crilley P, Patchefsky A, Schiffman RL, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation.Chest. 1992;101:775–778.

    Article  PubMed  CAS  Google Scholar 

  21. 21.

    Yoshihara S, Tateishi U, Ando T, et al. Lower incidence of bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning.Bone Marrow Transplant. 2005;35:1195–1200.

    Article  PubMed  CAS  Google Scholar 

  22. 22.

    Calhoon JH, Levine S, Anzueto A, Bryan CL, Trinkle JK. Lung transplantation in a patient with a prior bone marrow transplant.Chest. 1992;102:948.

    Article  PubMed  CAS  Google Scholar 

  23. 23.

    Boas SR, Noyes BE, Kurland G, Armitage J, Orenstein D. Pediatric lung transplantation for graft-versus-host disease following bone marrow transplantation.Chest. 1994;105:1584–1586.

    Article  PubMed  CAS  Google Scholar 

  24. 24.

    Gascoigne A, Corris P. Lung transplants in patients with prior bone marrow transplants.Chest. 1994;105:327.

    Article  PubMed  CAS  Google Scholar 

  25. 25.

    Svendsen UG, Aggestrup S, Heilmann C, et al. Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow.Eur Respir J. 1995;8:334–337.

    Article  PubMed  CAS  Google Scholar 

  26. 26.

    Rabitsch W, Deviatko E, Keil F, et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation.Transplantation. 2001;71:1341–1343.

    Article  PubMed  CAS  Google Scholar 

  27. 27.

    Heath JA, Kurland G, Spray TL, et al. Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience.Transplantation. 2001;72:1986–1990.

    Article  PubMed  CAS  Google Scholar 

  28. 28.

    Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N. Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation.Ann Thorac Surg. 2005;79:1051–1052.

    Article  PubMed  Google Scholar 

  29. 29.

    Pechet TV, de le Morena M, Mendeloff EN, Sweet SC, Shapiro SD, Huddleston CB. Lung transplantation in children following treatment for malignancy.J Heart Lung Transplant. 2003;22: 154–160.

    Article  PubMed  Google Scholar 

  30. 30.

    Veeken C, Palmer SM, Davis RD, Grichnik KP. Living-related lobar lung transplantation.J Cardiothorac Vasc Anesth. 2004;18:506–511.

    Article  PubMed  Google Scholar 

  31. 31.

    Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation.Chest. 1984;86:824–829.

    Article  PubMed  CAS  Google Scholar 

  32. 32.

    Al-Githmi I, Batawil N, Shigemura N, et al. Bronchiolitis obliterans following lung transplantation.Eur J Cardiothorac Surg. 2006;30:846–851.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Hirokazu Okumura or Shigeki Ohtake or Yasuo Ontachi or Jun Ozaki or Shigeru Shimadoi or Yuko Waseda or Yukio Kondo or Hirohito Yamazaki or Akiyoshi Takami or Masahide Yasui or Hiroshi Date or Shinji Nakao.

About this article

Cite this article

Okumura, H., Ohtake, S., Ontachi, Y. et al. Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?. Int J Hematol 86, 369–373 (2007). https://doi.org/10.1532/IJH97.07045

Download citation

Key words

  • Living-donor lung transplantation
  • Bronchiolitis obliterans (BO)
  • Allogeneic hematopoietic stem cell transplantation
  • Graft-versus-host disease (GVHD)